Showing results (1-10 of 320) with videos related to

Sort By:
Pageof 32
The American Journal of Clinical Nutrition|July 1, 1995
Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfyJ R Hibbeln, N Salem
Journal of Lipid Research|August 3, 2001
Physiological compartmental analysis of alpha-linolenic acid metabolism in adult humansR J Pawlosky, J R Hibbeln, J A Novotny, et al.
Biological Psychiatry|August 26, 1998
Essential fatty acids predict metabolites of serotonin and dopamine in cerebrospinal fluid among healthy control subjects, and early- and late-onset alcoholicsJ R Hibbeln, M Linnoila, J C Umhau, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 30, 2015
Distribution of omega-6 and omega-3 polyunsaturated fatty acids in the whole rat body and 25 compartmentsN M Salem, Y H Lin, T Moriguchi, et al.
The American Journal of Clinical Nutrition|January 5, 2000
Plasma total cholesterol concentrations do not predict cerebrospinal fluid neurotransmitter metabolites: implications for the biophysical role of highly unsaturated fatty acidsJ R Hibbeln, J C Umhau, D T George, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|September 12, 2006
Cultural symbolism of fish and the psychotropic properties of omega-3 fatty acidsL C Reis, J R Hibbeln
Biological Psychiatry|August 26, 1998
A replication study of violent and nonviolent subjects: cerebrospinal fluid metabolites of serotonin and dopamine are predicted by plasma essential fatty acidsJ R Hibbeln, J C Umhau, M Linnoila, et al.
Biological Psychiatry|April 1, 1989
Are disturbances in lipid-protein interactions by phospholipase-A2 a predisposing factor in affective illness?J R Hibbeln, J W Palmer, J M Davis
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|July 16, 2002
[Clinical and biological surveillance after radiotherapy for localized prostate cancer]N Salem
The American Journal of Psychiatry|December 1, 2001
A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophreniaW S Fenton, F Dickerson, J Boronow, et al.
Pageof 32